{
    "organizations": [],
    "uuid": "32bfba106d0afc712645acb5a112270a199d3b75",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indias-cipla-gets-final-nod-for-ge/brief-indias-cipla-gets-final-nod-for-generic-vazculep-others-idUSFWN1S9002",
    "ord_in_thread": 0,
    "title": "BRIEF-India's Cipla Gets Final Nod For Generic Vazculep, Others",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2 (Reuters) - Cipla Ltd:\n* GETS FINAL NOD FOR GENERIC VAZCULEP, GENERIC PHENYLEPHRINE HYDROCHLORIDE INJECTION USP, 10 MG/ML SINGLE-DOSE VIAL, GENERIC AROMASIN\n* PRODUCTS ARE MANUFACTURED AT CO'S GOA PLANT Source text - bit.ly/2JMr1lF Further company coverage:\n ",
    "published": "2018-05-02T11:43:00.000+03:00",
    "crawled": "2018-05-02T16:12:09.014+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "cipla",
        "ltd",
        "get",
        "final",
        "nod",
        "generic",
        "vazculep",
        "generic",
        "phenylephrine",
        "hydrochloride",
        "injection",
        "usp",
        "vial",
        "generic",
        "aromasin",
        "product",
        "manufactured",
        "co",
        "goa",
        "plant",
        "source",
        "text",
        "company",
        "coverage"
    ]
}